Psychopharmacologic Therapies in Dermatology: An Update
Authors:
- John KooJKJohn Koo
- 1 October 2005
- journal article
- review article
- Published by Elsevier in Dermatologic Clinics
- Vol. 23 (4) , 735-744
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Paroxetine in the Treatment of Generalized Anxiety DisorderThe Journal of Clinical Psychiatry, 2001
- Efficacy of Extended-Release Venlafaxine in Nondepressed Outpatients With Generalized Anxiety DisorderAmerican Journal of Psychiatry, 2000
- Once-Daily Venlafaxine Extended Release (XR) Compared With Fluoxetine in Outpatients With Depression and AnxietyThe Journal of Clinical Psychiatry, 1999
- Venlafaxine XR (V XR) is an efficacious short-and long-term treatment for generalized anxiety disorder (GAD)European Neuropsychopharmacology, 1998
- Double-blind, placebo-controlled study of once daily venlafaxine XR In outpatients with generalized anxiety disorderEuropean Neuropsychopharmacology, 1998
- Neuroleptic IntoleranceSchizophrenia Bulletin, 1997
- Delusional parasitosis: A dermatologic, psychiatric, and pharmacologic approachJournal of the American Academy of Dermatology, 1993
- Mechanism of action of doxepin in the treatment of chronic urticariaFundamental & Clinical Pharmacology, 1990
- Psychogenic facial pain: presentation and treatment.BMJ, 1984
- Inhibition of histamine-induced pruritus by topical tricyclic antidepressantsJournal of the American Academy of Dermatology, 1981